Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2012, Article ID 391734, 17 pages
http://dx.doi.org/10.6064/2012/391734
Review Article

Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It

Department of Angiology and Blood Coagulation, Via Albertoni 15, 40138 Bologna (BO), Italy

Received 16 August 2012; Accepted 10 September 2012

Academic Editors: K. C. Dellsperger, B. Rippe, and H. Sheng

Copyright © 2012 Gualtiero Palareti. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Venous thromboembolism (VTE) that includes deep vein thrombosis and/or pulmonary embolism is a frequent, severe, and potentially lethal disease. After a first episode, VTE has a strong tendency to recur. While VTE is an acute disease, it may have variable outcomes in early and late phases after initial presentation. Furthermore, the incidence of late, clinically important consequences (postthrombotic syndrome and/or chronic thromboembolic pulmonary hypertension) increases in case of recurrent events. The aims of the present review are (i) to analyze the incidence and risk factors for recurrence of VTE (either those related to the type of first thrombotic event or to the patients), the risks associated with occurrence of recurrent events, and the problems linked to the diagnosis, not always easy, of recurrent events; (ii) to discuss whether or not it is possible to predict the individual risk of recurrence after a first event, by stratifying patients at high or low risk of recurrence, and how this can influence their treatment; (iii) to comment what the current guidelines and guidance suggest/recommend about anticoagulant treatment after a first VTE event and, finally, to propose practical indications on how to manage individual patients affected by VTE.